Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

@article{Bonkovsky1999ReductionOH,
  title={Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.},
  author={Herbert L. Bonkovsky and Jacqueline Woolley},
  journal={Hepatology},
  year={1999},
  volume={29 1},
  pages={
          264-70
        }
}

• Herbert L. Bonkovsky, Jacqueline Woolley
• Published in Hepatology 1999

The natural history, prognosis, and clinical significance of chronic hepatitis C are highly variable and somewhat controversial. The purpose of this study was to evaluate the effect of chronic hepatitis C infection on patients' perceptions of health-related quality of life (HRQOL) and to evaluate whether treatment with interferon improves HRQOL. A total of 642 patients with compensated liver disease who were enrolled in a multicenter trial of interferon therapy for chronic hepatitis C had… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed